Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes

被引：31
作者：
Johnson, J. A. [1 ]
Pollak, M. [2 ]
机构：
[1] Univ Alberta, Sch Publ Hlth, Ctr Hlth Res Innovat, Edmonton, AB T6G 2E1, Canada
[2] McGill Univ, Dept Oncol, Montreal, PQ, Canada
来源：
DIABETOLOGIA | 2010年 / 53卷 / 10期
基金：
加拿大健康研究院;
关键词：
COLORECTAL-CANCER; BLOOD-GLUCOSE; RECEPTOR ISOFORM; C-PEPTIDE; GROWTH; METFORMIN; CELLS; COMPLICATIONS; THERAPIES; MORTALITY;
D O I：
10.1007/s00125-010-1855-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2086 / 2088
页数：3
相关论文
共 50 条
  • [41] Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
    He, Xiaoning
    Shi, Lizheng
    Wu, Jing
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 1089 - 1098
  • [42] Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
    Arima, Reetta
    Marttila, Mikko
    Hautakoski, Ari
    Arffman, Martti
    Sund, Reijo
    Ilanne-Parikka, Pirjo
    Kangaskokko, Jenni
    Laara, Esa
    Puistola, Ulla
    Hinkula, Marianne
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 636 - 641
  • [43] A Model for Glucose, Insulin, and Beta-Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes
    Ribbing, Jakob
    Hamren, Bengt
    Svensson, Maria K.
    Karlsson, Mats O.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (08) : 861 - 872
  • [44] Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
    Tseng, Chin-Hsiao
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [45] Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
    Tseng, Chin-Hsiao
    ONCOTARGET, 2017, 8 (12) : 19057 - 19064
  • [46] Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis
    Bosetti, Cristina
    Rosato, Valentina
    Buniato, Danilo
    Zambon, Antonella
    La Vecchia, Carlo
    Corrao, Giovanni
    ONCOLOGIST, 2013, 18 (02) : 148 - 156
  • [47] Potential of Fasting C-peptide to Glucose Ratio and Triglyceride Glucose Index as Markers for β-Cell Dysfunction and Insulin Resistance in Patients With Type 2 Diabetes on Insulin Therapy
    Essa, Breshan S.
    Meena, Mohammed Q.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [48] The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes
    Tuccori, Marco
    Wu, Jennifer W.
    Yin, Hui
    Majdan, Agnieszka
    Azoulay, Laurent
    DIABETES CARE, 2015, 38 (11) : 2083 - 2089
  • [49] The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
    Hsieh, Ming-Chia
    Lee, Tzu-Chi
    Cheng, Shu-Min
    Tu, Shih-Te
    Yen, Ming-Hong
    Tseng, Chin-Hsiao
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [50] The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
    Oppong, Bridget A.
    Pharmer, Lindsay A.
    Oskar, Sabine
    Eaton, Anne
    Stempel, Michelle
    Patil, Sujata
    King, Tari A.
    CANCER MEDICINE, 2014, 3 (04): : 1025 - 1034
12345